Clinical Trial: GDC-0449 in Treating Patients With High-Risk First Remission or Relapsed Multiple Myeloma Who Received an Autologous Stem Cell Transplant

Sponsor and Collaborators
Sidney Kimmel Comprehensive Cancer Center
National Cancer Institute (NCI)

Principal Investigator
Carol A. Huff, MD Sidney Kimmel Comprehensive Cancer Center

ClinicalTrials.gov Identifier
NCT01330173